Omniscan side effects - from FDA reports


In this review, we analyze Omniscan side effects by the time on the drug, gender and age of the people who have side effects while taking Omniscan. The review is based on 5,729 people who have side effects while taking the drug from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.


Omniscan

Omniscan has active ingredients of gadodiamide. (latest outcomes from Omniscan 5,732 users)


On Mar, 15, 2019

5,729 people who take Omniscan are studied.


Number of reports submitted per year:

Omniscan side effects.

Most common side effects over time *:

< 1 month:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anxiety
  • Pain
  • Deformity (disfigurement)
  • Vomiting
  • Skin tightness
  • Arthralgia (joint pain)
  • Scar
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
1 - 6 months:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Cellulitis (infection under the skin)
6 - 12 months:
  • Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
1 - 2 years:
  • Joint contracture (a permanent shortening of a muscle or joint)
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Swelling
2 - 5 years:
  • Renal failure chronic (long lasting kidney dysfunction)
  • Septic shock (shock due to blood infection)
  • White blood cell count increased
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Weight decreased
  • Arthralgia (joint pain)
  • Haemorrhagic ovarian cyst (bleeding ovarian cyst)
  • Laboratory test abnormal
5 - 10 years:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Mobility decreased (ability to move is reduced)
  • Nuclear magnetic resonance imaging brain abnormal
  • Anxiety
10+ years:
  • Skin lesion
not specified:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anxiety
  • Pain
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • Deformity (disfigurement)
  • Skin tightness
  • Scar
  • Skin fibrosis (fibrous tissue formation on skin)
  • Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)

Most common side effects by gender *:

female:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anxiety
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Pain
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • Skin tightness
  • Deformity (disfigurement)
  • Skin fibrosis (fibrous tissue formation on skin)
  • Scar
  • Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
male:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anxiety
  • Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  • Abasia (inability to walk)
  • Skin induration (an abnormally hard spot or area on the skin)
  • Oedema peripheral (superficial swelling)
  • Emotional distress
  • Pruritus (severe itching of the skin)
  • Skin hypertrophy (skin cells enlarges)
  • Swelling

Most common side effects by age *:

0-1:
  • Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  • Urticaria (rash of round, red welts on the skin that itch intensely)
2-9:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Biopsy brain abnormal
  • Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  • Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  • Flushing (the warm, red condition of human skin)
  • Pulmonary embolism (blockage of the main artery of the lung)
  • Scleral discolouration (change colour of sclera)
  • Tenderness (pain or discomfort when an affected area is touched)
10-19:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Renal osteodystrophy (a bone disease occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood)
  • Xerosis (abnormal dryness of the skin or mucus membranes)
  • Skin plaque (red, scaly patches to appear on the skin)
  • Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  • Ascites (accumulation of fluid in the abdominal cavity)
  • Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  • Biopsy brain abnormal
  • Cardiac arrest
20-29:
  • Urticaria (rash of round, red welts on the skin that itch intensely)
  • Abasia (inability to walk)
  • Gait disturbance
  • Oedema peripheral (superficial swelling)
  • Abdominal abscess (collection of pus in abdomen)
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • Cellulitis (infection under the skin)
  • Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  • Hypoaesthesia (reduced sense of touch or sensation)
  • Pain
30-39:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Skin tightness
  • Skin induration (an abnormally hard spot or area on the skin)
  • Deformity (disfigurement)
  • Arthralgia (joint pain)
  • Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  • Urticaria (rash of round, red welts on the skin that itch intensely)
  • Anxiety
  • Scar
40-49:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Skin tightness
  • Skin induration (an abnormally hard spot or area on the skin)
  • Arthralgia (joint pain)
  • Oedema peripheral (superficial swelling)
  • Abasia (inability to walk)
  • Anxiety
  • Erythema (redness of the skin)
50-59:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Skin tightness
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Anxiety
  • Arthralgia (joint pain)
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • Deformity (disfigurement)
  • Abasia (inability to walk)
  • Skin induration (an abnormally hard spot or area on the skin)
  • Joint range of motion decreased (disease of joint movement)
60+:
  • Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)
  • Skin tightness
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  • Anxiety
  • Arthralgia (joint pain)
  • Abasia (inability to walk)
  • Pruritus (severe itching of the skin)
  • Asthenia (weakness)
  • Pain

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

Related studies

All Omniscan side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Omniscan (gadodiamide) is often used to treat arteriogram. Find out below the conditions the drugs are used for and how effective they are.


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!